EosGene Therapeutics is pioneering the next generation of gene therapy with NanoSyringe, a light-activated delivery platform designed for precise, scalable, and cost-effective genetic medicine. The therapy will remove the need for painful eye injections in those suffering from diabetic retinopathy and age-related macular degeneration.
